Complete Filing Data
Burcon NutraScience Corp reported Cash And Cash Equivalents of $7.00 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Burcon NutraScience Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$4.3M | -$2.4M | -$939.8K |
| Revenue From Royalties | $171.5K | $8.6K | $31.1K |
| Research And Development Expense | $1.8M | $414.0K | $721.9K |
| Profit Loss From Operating Activities | -$7.4M | -$4.6M | -$3.7M |
| Interest Expense | $72.5K | $770.4K | $589.3K |
| General And Administrative Expense | $4.3M | $3.7M | $2.2M |
| Comprehensive Income | -$10.3M | -$617.5K | -$4.6M |
| Adjustments For Reconcile Profit Loss | -$5.4M | -$2.4M | -$2.6M |
| Adjustments For Interest Expense | $72.5K | $770.4K | $589.3K |
| Profit Loss | -$10.3M | -$617.5K | -$4.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Cash And Cash Equivalents | $7.0M | $14.0M | $15.0M | $489.2K |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $51.5K | $894.5K | $101.2K | |
| Purchase Of Interests In Investments Accounted For Using Equity Method | $0.00 | $0.00 | $13.0M | |
| Losses On Disposals Of Property Plant And Equipment | $0.00 | $0.00 | $949.00 | |
| Increase Decrease Through Exercise Of Warrants Equity | $211.5K | $5.0M | $531.9K | |
| Cash Flows From Used In Operations | -$5.9M | -$2.3M | -$2.6M | |
| Cash Flows From Used In Operating Activities | -$5.9M | -$3.0M | -$3.4M | |
| Cash Flows From Used In Investing Activities | -$1.2M | -$2.7M | -$14.5M | |
| Cash Flows From Used In Financing Activities | $174.1K | $4.7M | $32.4M | |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | $0.00 | $0.00 | $949.00 | |
| Adjustments For Increase Decrease In Trade And Other Payables | -$509.1K | $190.5K | $39.8K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $138.4K | -$6.5K | -$205.6K | |
| Trade And Other Current Receivables | $200.3K | $338.7K | ||
| Trade And Other Current Payables | $906.7K | $1.4M | ||
| Retained Earnings | -$109.2M | -$99.0M | ||
| Property Plant And Equipment | $859.4K | $1.0M | ||
| Noncurrent Lease Liabilities | $58.7K | $5.3K | ||
| Non Current Deferred Development Costs | $6.2M | $4.5M | ||
| Liabilities | $1.1M | $1.5M | ||
| Investment Accounted For Using Equity Method | $13.4M | $16.4M | ||
| Goodwill | $1.3M | $1.3M | ||
| Equity And Liabilities | $29.3M | $37.7M | ||
| Current Liabilities | $1.0M | $1.4M | ||
| Current Lease Liabilities | $14.4K | $28.4K | ||
| Current Assets | $7.6M | $14.6M | ||
| Assets | $29.3M | $37.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Proceeds From Issuing Shares | 272.0K | 5.0M | 25.8M |
| Proceeds From Issuing Other Equity Instruments | $0.00 | $0.00 | $1.8M |
| Proceeds From Issue Of Bonds Notes And Debentures | $0.00 | $0.00 | $9.5M |
| Proceeds From Current Borrowings | $0.00 | $0.00 | $250.0K |
| Payments Of Lease Liabilities Classified As Financing Activities | $0.00 | $90.2K | $0.00 |
| Payments For Share Issue Costs | $0.00 | $239.6K | $1.4M |
| Payments For Development Project Expenditure | $1.2M | $2.0M | $1.5M |
| Increase Decrease In Cash And Cash Equivalents | -$7.0M | -$1.1M | $14.5M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$548.00 | -$4.5K | $1.8K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Research Income | $0.00 | $250.0K | $0.00 |
| Repayments Of Current Borrowings | $0.00 | $0.00 | $1.5M |
| Repayments Of Bonds Notes And Debentures | $0.00 | $0.00 | $2.0M |
| Portfolio And Other Management Fee Income | $114.4K | $342.5K | $364.2K |
| Interest Received Classified As Operating Activities | -$36.7K | -$156.0K | -$79.8K |
| Interest Received Classified As Investing Activities | $36.7K | $156.0K | $79.8K |
| Interest Paid Classified As Operating Activities | $0.00 | $572.1K | $672.2K |
| Intellectual Property Expense | $1.4M | $786.0K | $846.1K |
| Increase Decrease Through Sharebased Payment Transactions | $1.9M | $1.9M | $565.6K |
| Increase Decrease Through Exercise Of Options | $60.5K | $39.1K | $71.1K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$3.6K | -$4.3K | $2.2K |
| Gains Losses On Change In Fair Value Of Derivatives | $0.00 | $0.00 | $5.4K |
| Gain On Dilution Of Investment In Merit Functional Foods Corporation | $961.2K | $6.4M | $0.00 |
| Finance Income | $434.5K | $446.8K | $247.9K |
| Expense By Nature | $7.6M | $4.9M | $3.8M |
| Dilution Gain Of Investment | $961.2K | $6.4M | $0.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $548.00 | $4.5K | -$1.8K |
| Adjustments For Sharebased Payments | $1.4M | $1.6M | $515.0K |
| Adjustments For Interest Accretion | -$343.5K | -$307.9K | -$144.3K |
| Adjustments For Finance Income | $798.00 | $6.1K | $0.00 |
| Adjustments For Depreciation And Amortisation Expense | $156.0K | $123.2K | $37.3K |
| Adjustments For Decrease Increase In Inventories | $287.00 | -$331.00 | -$132.1K |
| Warrants | $0.00 | $594.6K | |
| Warrant Issue Related Costs | $785.00 | $237.9K | |
| Share Issue Related Cost | $4.3K | $1.4M | |
| Options | $7.0M | $6.5M | |
| Issued Capital | $114.6M | $114.1M | |
| Inventories | $0.00 | $132.5K | |
| Current Prepaid Expenses | $291.6K | $154.8K | |
| Additional Paidin Capital | $15.9M | $14.1M |
Most recent annual filing with the SEC: August 1, 2022
Data sourced from SEC EDGAR public filings as of August 5, 2026.